SKIN icon

The Beauty Health Co

1.27 USD
-0.20
13.61%
At close Mar 3, 4:00 PM EST
After hours
1.27
+0.00
0.00%
1 day
-13.61%
5 days
-19.11%
1 month
-23.49%
3 months
-11.19%
6 months
-25.73%
Year to date
-21.12%
1 year
-65.21%
5 years
-90.12%
10 years
-90.12%
 

About: The Beauty Health Co is a category-creating beauty health company that along with its subsidiaries designs, develops, manufactures, markets, and sells esthetic technologies and products. The company's brand portfolio includes Hydrafacial, SkinStylus, and Keravive, offering Syndeo device, SkinStylus SteriLock Microsystem, Keravive Peptide Solution and other products.

Employees: 881

0
Funds holding %
of 7,290 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

4,561% more call options, than puts

Call options by funds: $6.06M | Put options by funds: $130K

11% more capital invested

Capital invested by funds: $105M [Q3] → $116M (+$11.2M) [Q4]

0.13% more ownership

Funds ownership: 58.88% [Q3] → 59.01% (+0.13%) [Q4]

3% less repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 30

11% less funds holding

Funds holding: 114 [Q3] → 101 (-13) [Q4]

46% less first-time investments, than exits

New positions opened: 14 | Existing positions closed: 26

100% less funds holding in top 10

Funds holding in top 10: 1 [Q3] → 0 (-1) [Q4]

Research analyst outlook

We haven’t received any recent analyst ratings for SKIN.

Financial journalist opinion

Neutral
Business Wire
1 week ago
SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of The Beauty Health Company (NASDAQ: SKIN) and Encourages Long-Term Shareholders to Contact the Firm
PHILADELPHIA--(BUSINESS WIRE)--Kaskela Law LLC announces that it is investigating The Beauty Health Company (NASDAQ: SKIN) (“Beauty Health”) on behalf of the company's shareholders. Click here for additional information: https://kaskelalaw.com/case/the-beauty-health-company/ Since March 2024, shares of Beauty Health's common stock have declined in value from a trading price of approximately $4.50 per share to a current trading price of below $1.75 per share, a decline of over 60% in value. The.
SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of The Beauty Health Company (NASDAQ: SKIN) and Encourages Long-Term Shareholders to Contact the Firm
Neutral
Business Wire
2 months ago
BeautyHealth Appoints Stephen J. Fanning to Board of Directors
LONG BEACH, Calif.--(BUSINESS WIRE)--The Beauty Health Company, home to flagship brand Hydrafacial, appoints medical aesthetics veteran, Stephen J. Fanning, to its Board of Directors.
BeautyHealth Appoints Stephen J. Fanning to Board of Directors
Neutral
Business Wire
2 months ago
BeautyHealth Releases 2024 Skintuition Report
LONG BEACH, Calif.--(BUSINESS WIRE)--BeautyHealth Releases 2024 Skintuition Report.
BeautyHealth Releases 2024 Skintuition Report
Neutral
Business Wire
2 months ago
Glancy Prongay & Murray LLP Announces Investigation of The Beauty Health Company (SKIN) f/k/a Vesper Healthcare Acquisition Corp.
NEW YORK--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”) announces its investigation of The Beauty Health Company (NASDAQ: SKIN) f/k/a Vesper Healthcare Acquisition Corp. concerning the Company and its directors' and officers' possible violations of state laws. If you own Beauty Health stock, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Tom Kennedy, of GPM, 230.
Glancy Prongay & Murray LLP Announces Investigation of The Beauty Health Company (SKIN) f/k/a Vesper Healthcare Acquisition Corp.
Neutral
Zacks Investment Research
3 months ago
Beauty Health (SKIN) International Revenue Performance Explored
Examine Beauty Health's (SKIN) international revenue patterns and their implications on Wall Street's forecasts and the prospective trajectory of the stock.
Beauty Health (SKIN) International Revenue Performance Explored
Neutral
Seeking Alpha
3 months ago
The Beauty Health Company (SKIN) Q3 2024 Earnings Call Transcript
The Beauty Health Company (NASDAQ:SKIN ) Q3 2024 Results Conference Call November 12, 2024 4:30 PM ET Company Participants Norberto Aja - Investor Relations Marla Beck - President and CEO Mike Monahan - CFO Conference Call Participants Oliver Chen - TD Cowen Ashley Helgans - Jefferies Allen Gong - JPMorgan Susan Anderson - Canaccord Genuity Bruce Jackson - Benchmark Company Jon Block - Stifel Linda Bolton Weiser - DA Davidson Korinne Wolfmeyer - Piper Sandler Olivia Tong - Raymond James Operator Good day, and welcome to The Beauty Health 2024 Third Quarter Earnings Conference Call. All participants will be in listen only mode.
The Beauty Health Company (SKIN) Q3 2024 Earnings Call Transcript
Negative
Zacks Investment Research
3 months ago
The Beauty Health Company (SKIN) Reports Q3 Loss, Tops Revenue Estimates
The Beauty Health Company (SKIN) came out with a quarterly loss of $0.15 per share versus the Zacks Consensus Estimate of a loss of $0.12. This compares to earnings of $0.05 per share a year ago.
The Beauty Health Company (SKIN) Reports Q3 Loss, Tops Revenue Estimates
Neutral
Business Wire
3 months ago
BeautyHealth Reports Third Quarter 2024 Financial Results
LONG BEACH, Calif.--(BUSINESS WIRE)--The Beauty Health Company reports third quarter 2024 financial results. Improved profitability reflects early success of strategic initiatives.
BeautyHealth Reports Third Quarter 2024 Financial Results
Neutral
Business Wire
3 months ago
BeautyHealth to Report Third Quarter 2024 Financial Results on November 12, 2024
LONG BEACH, Calif.--(BUSINESS WIRE)--The Beauty Health Company, home to flagship brand Hydrafacial™, will report third quarter 2024 financial results on Tuesday, November 12.
BeautyHealth to Report Third Quarter 2024 Financial Results on November 12, 2024
Neutral
Business Wire
4 months ago
Hydrafacial Announces Video Poster Abstract Presentation at the 2024 American Society for Dermatologic Surgery's Annual Meeting (ASDS): Hydrafacial enhances the outcomes of non-ablative laser and IPL treatments
LONG BEACH, Calif.--(BUSINESS WIRE)--Hydrafacial Announces Video Poster Abstract Presentation at the 2024 American Society for Dermatologic Surgery's Annual Meeting (ASDS).
Hydrafacial Announces Video Poster Abstract Presentation at the 2024 American Society for Dermatologic Surgery's Annual Meeting (ASDS): Hydrafacial enhances the outcomes of non-ablative laser and IPL treatments
Charts implemented using Lightweight Charts™